Martin Mackay
Affiliations
- Director at Charles River Laboratories International Inc. (CRL), 2025-05-23
- Director at Springworks Therapeutics Inc. (SWTX), 2025-05-15
- Director at Rallybio Corp (RLYB), 2025-05-15
- Director at 5:01 Acquisition Corp. (FVAM), 2020-10-21
- Evp & Global Head Of R&D at Alexion Pharmaceuticals Inc (ALXN), 2017-03-02
- Senior Vice President at Pfizer Inc (PFE), 2010-05-18
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| RLYB | $10.65 | 4,496 | $47,882.40 | 282,609 | 2022-01-11 | Filing |
| RLYB | $10.10 | 5,504 | $55,590.40 | 278,113 | 2022-01-10 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ALXN | $132.50 | 370 | $49,025.00 | 50,688 | 2017-03-01 | Filing |
| ALXN | $131.70 | 625 | $82,312.50 | 38,258 | 2017-02-28 | Filing |
| ALXN | $131.20 | 860 | $112,832.00 | 38,883 | 2017-02-27 | Filing |
| ALXN | $126.84 | 217 | $27,524.28 | 39,743 | 2017-02-09 | Filing |
| ALXN | $126.88 | 18 | $2,283.84 | 39,960 | 2017-02-06 | Filing |